Spotlight
Topics
DI Executive
Subscribe
- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
Leveraging a variety of artificial intelligence (AI) capabilities, the newly launched Voluson Signature 20 and 18 ultrasound devices may significantly enhance efficiency of common ultrasound exams for women.
GE HealthCare, the manufacturer of the Voluson Signature 20 and 18 ultrasound devices, said key efficiencies include:
• a 48 percent time reduction for performing fetal heart assessments due to a fetalHS feature, which provide stepwise AI guidance to identify normal fetal heart anatomy;
The SonoLyst feature, a suite of automated AI tools available with the newly launched Voluson Signature 20 and 18 ultrasound devices, reportedly facilitates a 40 percent time reduction for performing second trimester exams as per standards from the International Society of Ultrasound in Obstretics and Gynecology (ISUOG). (Image courtesy of GE HealthCare.)
• a 40 percent time reduction for performing second trimester exams as per standards from the International Society of Ultrasound in Obstretics and Gynecology (ISUOG) due to the SonoLyst feature, a suite of automated AI tools; and
• a 76 percent keystroke reduction with the automated plane alignment and measurements of the SonoPelvicFloor feature.
"We've seen huge advancements in ultrasound technology, including the use of AI, resulting in a new era of ultrasound scanning. The new Voluson Signature series features innovative tools clinicians can rely on, and the automated functions help reduce work stress and improve workflows," noted Ben Csapo, M.D., a maternal fetal medicine specialist in Graz, Austria.
Recent Videos
Related Content
Mammography Study Suggests DBT-Based AI May Help Reduce Disparities with Breast Cancer Screening
December 13th 2024Article
New research suggests that AI-powered assessment of digital breast tomosynthesis (DBT) for short-term breast cancer risk may help address racial disparities with detection and shortcomings of traditional mammography in women with dense breasts.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Podcast
Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography News: FDA Grants Expanded 510(k) Clearance for AI-Powered SmartMammo Dx DBT Software
November 29th 2024Article
Originally cleared by the FDA in 2021, the SmartMammo Dx software for digital breast tomosynthesis (DBT) can now be utilized with the Senographe Pristina mammography systems from GE HealthCare.
